Christopher B. Granger
Duke University(US)Sorbonne Université(FR)Clinical Research Institute(US)Pitié-Salpêtrière Hospital(FR)Duke Institute for Health Innovation(US)Duke Medical Center(US)Société Française de Cardiologie(FR)Duke University Health System(US)Duke University Hospital(US)Hôpital Charles-Foix(FR)Fondation pour l’innovation en Cadiométabolisme et Nutrition(FR)Stanford University(US)
Publications by Year
Research Areas
Acute Myocardial Infarction Research, Atrial Fibrillation Management and Outcomes, Heart Failure Treatment and Management, Cardiac Imaging and Diagnostics, Antiplatelet Therapy and Cardiovascular Diseases
Most-Cited Works
- → 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction(2012)4,718 cited
- → Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial(2003)2,956 cited
- → Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial(2003)2,608 cited
- → Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events(2003)2,333 cited
- → 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary(2012)2,229 cited
- → Fundamentals of Clinical Trials(2015)2,217 cited